Source link : https://www.newshealth.biz/health-news/novel-gene-therapy-for-neovascular-age-related-macular-degeneration/
A novel gene therapy (ABBV-RGX-314) was well tolerated and reduced treatment burden in patients with bilateral neovascular age-related macular degeneration (AMD), according to results of a phase II study presented at the American Academy of Ophthalmology (AAO) meeting. MedPage Today brought together three expert leaders in the field: Moderator Peter K. Kaiser, MD, of the […]
Author : News Health
Publish date : 2024-11-04 19:36:21
Copyright for syndicated content belongs to the linked Source.